These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34452307)

  • 21. Ontogeny of the B- and T-cell response in a primary Zika virus infection of a dengue-naïve individual during the 2016 outbreak in Miami, FL.
    Ricciardi MJ; Magnani DM; Grifoni A; Kwon YC; Gutman MJ; Grubaugh ND; Gangavarapu K; Sharkey M; Silveira CGT; Bailey VK; Pedreño-Lopez N; Gonzalez-Nieto L; Maxwell HS; Domingues A; Martins MA; Pham J; Weiskopf D; Altman J; Kallas EG; Andersen KG; Stevenson M; Lichtenberger P; Choe H; Whitehead SS; Sette A; Watkins DI
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006000. PubMed ID: 29267278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dengue Virus and Zika Virus Seroprevalence in the South Pacific Populations of the Cook Islands and Vanuatu.
    Saretzki CEB; Dobler G; Iro E; Heussen N; Küpper T
    Viruses; 2024 May; 16(5):. PubMed ID: 38793688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High Zika Virus Seroprevalence in Salvador, Northeastern Brazil Limits the Potential for Further Outbreaks.
    Netto EM; Moreira-Soto A; Pedroso C; Höser C; Funk S; Kucharski AJ; Rockstroh A; Kümmerer BM; Sampaio GS; Luz E; Vaz SN; Dias JP; Bastos FA; Cabral R; Kistemann T; Ulbert S; de Lamballerie X; Jaenisch T; Brady OJ; Drosten C; Sarno M; Brites C; Drexler JF
    mBio; 2017 Nov; 8(6):. PubMed ID: 29138300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of the immunoglobulin G avidity assay to differentiate between recent Zika and past dengue virus infections.
    Furuya AKM; Hunt D; George KS; Dupuis AP; Kramer LD; Shi PY; Wong S
    Clin Sci (Lond); 2019 Apr; 133(7):859-867. PubMed ID: 30902827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A serological framework to investigate acute primary and post-primary dengue cases reporting across the Philippines.
    Biggs JR; Sy AK; Brady OJ; Kucharski AJ; Funk S; Reyes MAJ; Quinones MA; Jones-Warner W; Tu YH; Avelino FL; Sucaldito NL; Mai HK; Lien LT; Do Thai H; Nguyen HAT; Anh DD; Iwasaki C; Kitamura N; Yoshida LM; Tandoc AO; la Paz EC; Capeding MRZ; Padilla CD; Hafalla JCR; Hibberd ML
    BMC Med; 2020 Nov; 18(1):364. PubMed ID: 33243267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of Zika Virus Serological Testing Strategies in New York State.
    Lee WT; Wong SJ; Kulas KE; Dupuis AP; Payne AF; Kramer LD; Dean AB; St George K; White JL; Sommer JN; Ledizet M; Limberger RJ
    J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29263203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of serological and molecular methods for diagnosis of zika virus infections.
    Jääskeläinen AJ; Korhonen EM; Huhtamo E; Lappalainen M; Vapalahti O; Kallio-Kokko H
    J Virol Methods; 2019 Jan; 263():68-74. PubMed ID: 30342068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzyme-linked immunosorbent assays using virus-like particles containing mutations of conserved residues on envelope protein can distinguish three flavivirus infections.
    Tsai WY; Driesse K; Tsai JJ; Hsieh SC; Sznajder Granat R; Jenkins O; Chang GJ; Wang WK
    Emerg Microbes Infect; 2020 Dec; 9(1):1722-1732. PubMed ID: 32684139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seroprevalence, spatial dispersion and factors associated with flavivirus and chikungunha infection in a risk area: a population-based seroprevalence study in Brazil.
    Barreto FKA; Alencar CH; Araújo FMC; Oliveira RMAB; Cavalcante JW; Lemos DRQ; Farias LABG; Boriz ILF; Medeiros LQ; Melo MNP; Miyajima F; Siqueira AM; Freitas ARR; Cavalcanti LPG
    BMC Infect Dis; 2020 Nov; 20(1):881. PubMed ID: 33234110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus.
    Dejnirattisai W; Supasa P; Wongwiwat W; Rouvinski A; Barba-Spaeth G; Duangchinda T; Sakuntabhai A; Cao-Lormeau VM; Malasit P; Rey FA; Mongkolsapaya J; Screaton GR
    Nat Immunol; 2016 Sep; 17(9):1102-8. PubMed ID: 27339099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive Evaluation of Differential Serodiagnosis between Zika and Dengue Viral Infections.
    Chao DY; Whitney MT; Davis BS; Medina FA; Munoz JL; Chang GJ
    J Clin Microbiol; 2019 Mar; 57(3):. PubMed ID: 30541932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human T cell responses to Dengue and Zika virus infection compared to Dengue/Zika coinfection.
    Badolato-Corrêa J; Sánchez-Arcila JC; Alves de Souza TM; Santos Barbosa L; Conrado Guerra Nunes P; da Rocha Queiroz Lima M; Gandini M; Bispo de Filippis AM; Venâncio da Cunha R; Leal de Azeredo E; de-Oliveira-Pinto LM
    Immun Inflamm Dis; 2018 Jun; 6(2):194-206. PubMed ID: 29282904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained Specific and Cross-Reactive T Cell Responses to Zika and Dengue Virus NS3 in West Africa.
    Herrera BB; Tsai WY; Chang CA; Hamel DJ; Wang WK; Lu Y; Mboup S; Kanki PJ
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific detection of dengue and Zika virus antibodies using envelope proteins with mutations in the conserved fusion loop.
    Rockstroh A; Moges B; Barzon L; Sinigaglia A; Palù G; Kumbukgolla W; Schmidt-Chanasit J; Sarno M; Brites C; Moreira-Soto A; Drexler JF; Ferreira OC; Ulbert S
    Emerg Microbes Infect; 2017 Nov; 6(11):e99. PubMed ID: 29116222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zika virus antibody-positivity among symptomatic/asymptomatic pregnant women in the Aseer region displays pre-exposure to dengue viruses.
    Harish CC; Ayed AA; Alhanshani AA; Youssef AA; Esther P; Riyad AAM; Abdullah MA; Anandalakshmi S; Ashish K; Ahmed MAH
    Trop Biomed; 2023 Sep; 40(3):337-343. PubMed ID: 37897167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis of Zika virus infection on a nanotechnology platform.
    Zhang B; Pinsky BA; Ananta JS; Zhao S; Arulkumar S; Wan H; Sahoo MK; Abeynayake J; Waggoner JJ; Hopes C; Tang M; Dai H
    Nat Med; 2017 May; 23(5):548-550. PubMed ID: 28263312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serological tests reveal significant cross-reactive human antibody responses to Zika and Dengue viruses in the Mexican population.
    Zaidi MB; Cedillo-Barron L; González Y Almeida ME; Garcia-Cordero J; Campos FD; Namorado-Tonix K; Perez F
    Acta Trop; 2020 Jan; 201():105201. PubMed ID: 31562846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serodiagnosis of Zika virus (ZIKV) infections by a novel NS1-based ELISA devoid of cross-reactivity with dengue virus antibodies: a multicohort study of assay performance, 2015 to 2016.
    Steinhagen K; Probst C; Radzimski C; Schmidt-Chanasit J; Emmerich P; van Esbroeck M; Schinkel J; Grobusch MP; Goorhuis A; Warnecke JM; Lattwein E; Komorowski L; Deerberg A; Saschenbrecker S; Stöcker W; Schlumberger W
    Euro Surveill; 2016 Dec; 21(50):. PubMed ID: 28006649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of Association between Adverse Pregnancy Outcomes and Zika Antibodies among Pregnant Women in Thailand between 1997 and 2015.
    Ngo-Giang-Huong N; Leroi C; Fusco D; Cressey TR; Wangsaeng N; Salvadori N; Kongyai N; Sirirungsi W; Lallemant M; Auewarakul P; Khamduang W; Jourdain G
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice.
    Fowler AM; Tang WW; Young MP; Mamidi A; Viramontes KM; McCauley MD; Carlin AF; Schooley RT; Swanstrom J; Baric RS; Govero J; Diamond MS; Shresta S
    Cell Host Microbe; 2018 Nov; 24(5):743-750.e5. PubMed ID: 30439343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.